Sangamo Biosciences Short Ratio


Short Ratio Analysis

Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Sangamo Biosciences 
Short Ratio 
Short Interest 
Average Trading Volume 
10.77 times

Distress Driver Correlations

About Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare Sangamo Biosciences to competition

Sangamo Biosciences Short Ratio Assessment

Benchmark  Embed   Sangamo Biosciences Comparables 
Based on latest financial disclosure Sangamo Biosciences Inc has Short Ratio of 10.77 times. This is 155.21% higher than that of the Healthcare sector, and 145.33% higher than that of Biotechnology industry, The Short Ratio for all stocks is 376.55% lower than the firm.

Filter other Stocks by Short Ratio

Short Ratio Input Range 
Click to run this filter
Filter Other Equities
Found 10 equities by Short Ratio
2.61 times
GILD NMSGilead Sciences Inc
2.43 times
CELG NMSCelgene Corporation
1.72 times
BIIB NMSBiogen Inc
1.04 times
REGN NMSRegeneron Pharmaceuticals Inc
4.16 times
ALXN NMSAlexion Pharmaceuticals Inc
2.85 times
VRTX NMSVertex Pharmaceuticals Incorporated
4.29 times
ILMN NMSIllumina Inc
6.2 times
INCY NMSIncyte Corporation
4.29 times
BMRN NMSBioMarin Pharmaceutical Inc
3.67 times
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
Sangamo Biosciences Short Ratio Comparison
  Short Ratio 
Benchmark  Embed   Sangamo Biosciences Comparables 
Sangamo Biosciences is currently under evaluation in short ratio category among related companies.
Did you try this?
Run Portfolio Rebalancing Now

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Hide  View All  NextLaunch Portfolio Rebalancing
Return On Equity(26.82) %
Return On Asset(16.43) %
Profit Margin(172.98) %
Operating Margin(190.88) %
Current Valuation224.8 M
Shares Outstanding70.49 M
Shares Owned by Insiders4.18 %
Shares Owned by Institutions71.00 %
Number of Shares Shorted9.13 M
Price to Book2.30 times
Price to Sales13.75 times
Revenue29.99 M
Gross Profit39.54 M
EBITDA(56.16 M)
Net Income(51.88 M)
Cash and Equivalents187.58 M
Cash per Share2.66 times
Current Ratio18.94 times
Book Value Per Share2.55 times
Cash Flow from Operations(51.69 M)
Short Ratio10.77 times
One Year High9.91
One Year Low4.63
Earnings Per Share(0.74) times
Number of Employees119
Market Capitalization406.74 M
Total Asset197.05 M
Retained Earnings(385.75 M)
Working Capital119.14 M
Current Asset191.14 M
Current Liabilities10.09 M
Z Score-1.4